glp 1 drugs and rheumatoid arthritis ACR 2025: GLP-1 Reduce Flares GLP-1 agents 'can help lower

A., Stein C., et al., Do GLP1 Receptor Agonists Increase the Risk of Breast Cancer

Lilly Launches Trulicity in the US First Ever Ready-to-Use Once-Weekly GLP-1 Receptor Agonist Eli Lilly launches Trulicity in the US first ready-to-use once-weekly GLP-1, available with a savings program for commercially insured patients

Protecting muscle during the treatment period is not just about now it determines what happens if and when the drug is stopped

Specifically, the HR for HHF was 0.20 (95% CI 0.070.60) with GLP-1RAs and 0.77 (95% CI 0.640.92) without GLP-1RAs ( P -value for interaction 0.014)

That's arithmetic, not a pharmacological flaw unique to either compound

GLP-1 improvement of endothelial function, assessed by flow-mediated vasodilation, was also demonstrated during a hyperglycemic clamp in patients with T2DM and normoglycemic controls [616]